Glaucoma is a serious and lifelong eye disease that can lead to vision loss if not adequately treated and controlled. It is characterized by damage to a part of the eye called the optic nerve often due to increased intraocular pressure. There are several treatment options aimed at preventing further disease progression and loss of vision due to glaucoma.
Glaucoma can usually be treated and controlled using medicine(s), laser surgery, standard surgery, or a combination of these treatments. Medicines (eye drops) are typically the first step in the treatment of glaucoma patients.
Eye drops Preservative Free
- LATANOPROST
MDPF Areo Pump - LATANOPROST-TIMOLOL
MDPF Areo Pump - TRAVOPROST-TIMOLOL
MDPF Areo Pump
- TIMOLOL 0,25% & 0,5%
MD Novelia - DORZOLAMIDE-TIMOLOL
MD Novelia - DORZOLAMIDE
MD Novelia
- BRIMONIDINE-TIMOLOL
MD Novelia - BIMATOPROST 0,3%
MDPF Novelia - BIMATOPROST 0,3% - TIMOLOL
MD Novelia
Eye drops with preservative
- DORZOLAMIDE
- DORZOLAMIDE-TIMOLOL
- BRINZOLAMIDE-BRIMONIDINE
unique suspension
- TRAVOPROST
- TRAVOPROST-TIMOLOL
- BRINZOLAMIDE
unique suspension
- BIMATOPROST 0,1%
- BIMATOPROST 0,3%
- BRINZOLAMIDE-TIMOLOL
unique suspension
Tablets
- CETAZOLAMIDE
250 mg tablets. Pharma Therapeutic Group: carbonic anhydrase inhibitor
- EYE VOLTAGE
food supplement with citicoline + vit. B3
Pharmacovigilance
Space NTC
NTC España website